ArticleHeliyon2024

Safety, efficacy, and pharmacokinetics of nirmatrelvir and ritonavir in patients with severe COVID-19 and renal impairment: A case report.

Ren Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.